Intravenous Short-Term Infusion of Streptokinase in Acute Myocardial Infarction

AUTOR(ES)

Schröder, Rolf

RESUMO

Clinically encouraging results can be obtained with an intravenous high dosage, short-term infusion of streptokinase in patients with evolving myocardial infarction. The feasibility and efficacy of the systemic approach of streptokinase therapy is discussed in this report and includes topics such as recanalization success rate, restoration of coronary blood flow, residual coronary artery lesions, salvage of jeopardized myocardium, time limits of effective reperfusion, transluminal angioplasty, coronary bypass surgery, and mortality.

Documentos Relacionados

• High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
• Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
• Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.
• Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.
• Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents